What is the recommended dosing frequency for cephalexin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin Dosing Frequency

For most skin and soft tissue infections in adults, cephalexin should be dosed at 500 mg every 6 hours (four times daily), though 500 mg every 12 hours (twice daily) is acceptable for uncomplicated cases like simple cellulitis, streptococcal pharyngitis, and uncomplicated cystitis. 1

Adult Dosing by Indication

The FDA-approved dosing provides clear guidance 1:

  • Standard dosing: 250 mg every 6 hours (four times daily)
  • Moderate infections: 500 mg every 12 hours (twice daily) is specifically approved for:
    • Streptococcal pharyngitis
    • Skin and skin structure infections
    • Uncomplicated cystitis (patients >15 years)
  • Severe infections: Up to 4 g daily in divided doses; consider parenteral therapy if higher doses needed

Pediatric Dosing

Children require 25-50 mg/kg/day in divided doses 1:

  • Standard infections: Can be divided every 6 hours (QID) or every 12 hours (BID)
  • Otitis media: Requires 75-100 mg/kg/day in 4 divided doses
  • Streptococcal infections: Continue for at least 10 days

Recent evidence supports less frequent dosing in children with bone/joint infections—45 mg/kg (maximum 1.5 g) three times daily achieved 99% cure rates 2.

Evidence for Reduced Frequency Dosing

Multiple recent studies challenge traditional four-times-daily dosing:

  • Urinary tract infections: Two studies found no difference in treatment failure between twice-daily versus four-times-daily dosing (12.7% vs 17%, p=0.343 3; 18.7% vs 15.0%, p=0.465 4)
  • Pediatric osteoarticular infections: TID versus QID dosing showed equivalent clinical cure rates with no failures in either group 5

The key advantage of less frequent dosing is improved adherence without compromising efficacy, particularly important for outpatient therapy.

Clinical Decision Algorithm

For mild-moderate infections (simple cellulitis, pharyngitis, uncomplicated UTI):

  • Use 500 mg twice daily
  • Improves adherence, reduces cost
  • Supported by FDA labeling and recent clinical data

For moderate-severe infections (complicated SSTIs, suspected MSSA with systemic signs):

  • Use 500 mg four times daily
  • Optimizes PK/PD parameters 6
  • Particularly important for S. aureus infections

For severe/life-threatening infections:

  • Consider parenteral cephalosporins per IDSA guidelines 7
  • Cefazolin 1 g every 8 hours IV for adults, 33 mg/kg/dose every 8 hours IV for children

Important Caveats

  • Duration: Typically 5-7 days for most SSTIs; extend if not improving 7
  • Streptococcal infections: Treat for minimum 10 days 1
  • Cystitis: Continue 7-14 days 1
  • Refrigeration: Oral suspension stable 14 days refrigerated 1
  • MRSA coverage: Cephalexin is ineffective; use vancomycin, linezolid, or other MRSA-active agents if suspected 7

The shift toward twice-daily dosing for uncomplicated infections represents practical, evidence-based prescribing that balances pharmacology with real-world adherence challenges.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.